CS Diagnostics Corp. (CSDX)
OQB · Healthcare · Medical Devices
$0.05
-1.64%
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
Market Cap
$13.5M
Shares Outstanding
250.0M
P/S (TTM)
-79.8x
Exchange
OQB
Currency
USD
About CS Diagnostics Corp.
CS Diagnostics Corp. engages in designing, manufacturing, and selling of wellness and medical products in Germany and internationally. The company offers MEDUSA, proprietary surface disinfectant protection product; and CS-Protect Hydrogel, a proprietary oncology medical device used in radiation therapy. The company was formerly known as FlashZero Corp. and changed its name to CS Diagnostics Corp. in August 2023. The company was incorporated in 1996 and is based in Cheyenne, Wyoming.
Quarterly Financials
| Metric | 2024-09-30 | 2024-12-31 | 2025-09-30 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 8K | -106K | 23K | -94K |
| Operating Income | 536.00 | -13K | -182.00 | 39K |
| Net Income | 536.00 | -13K | -182.00 | 39K |
| Diluted EPS | $0.00 | $nan | $0.00 | $nan |
Annual Financials
| Metric | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Revenue | 0.00 | 0.00 |
| Operating Income | 761.00 | 71K |
| Net Income | 761.00 | 71K |
| Diluted EPS | $0.00 | $nan |